Steris (STE) EBITDA (2018 - 2026)

Steris has reported EBITDA for 8 years, with the latest figure at $273.2 million in Q4 2025.

• For the quarter ending Q4 2025, EBITDA rose 11.37% year-over-year to $273.2 million; the trailing twelve-month figure through Dec 2025 stood at $1.0 billion (up 14.96% YoY), and the FY2025 full-year result was $866.6 million, up 3.65% from the prior year.
• EBITDA for Q4 2025 stood at $273.2 million, up from $265.8 million in the prior quarter.
• The five-year high for EBITDA was $748.3 million in Q1 2023, with the low at -$306.4 million in Q3 2022.
• Average EBITDA over 5 years is $187.8 million, with a median of $200.3 million recorded in 2021.
• Peak annual rise in EBITDA reached 68697.62% in 2022, while the deepest fall reached 363.01% in 2022.
• Tracing STE's EBITDA over 5 years: stood at $202.9 million in 2021, then slipped by 5.98% to $190.8 million in 2022, then gained by 18.69% to $226.5 million in 2023, then climbed by 8.31% to $245.3 million in 2024, then gained by 11.37% to $273.2 million in 2025.
• The last three EBITDA figures came in at $273.2 million (Q4 2025), $265.8 million (Q3 2025), and $246.0 million (Q2 2025), per Business Quant data.

Peer Comparison